O papel da acupuntura auricular (AA) nos homens que recebem hormônio luteinizante-releasing hormone (LHRH) análogos para o cancro da próstata tem sido investigado por um grupo de investigação no Reino Unido. Sintomas vasomotores semelhantes aos observados em mulheres na pós-menopausa pode afectar a qualidade de vida de tais homens. Sessenta pacientes (idade mediana 74 anos) receberam AA semana durante 10 semanas. Noventa e cinco por cento dos pacientes relataram uma diminuição na gravidade dos sintomas, a partir de um sintoma da pontuação média de 5,0 para 2,1. Os autores concluíram que a melhora sintomática observada com AA foi comparável ao obtido com a farmacoterapia e que, com base na análise de custos, AA representava uma alternativa viável. (Acupuntura auricular: um novo tratamento para os sintomas vasomotores associados luteinizante-tratamento com o agonista do hormônio liberador de hormônio de câncer de próstata. BJU Int. 2008 Aug 14).
AURICULAR ACUPUNCTURE FOR VASOMOTOR SYMPTOMS IN PROSTATE CANCER
The role of auricular acupuncture (AA) in men receiving luteinising-hormone releasing hormone (LHRH) analogues for cancer of the prostate has been investigated by a research group in the UK. Vasomotor symptoms similar to those observed in postmenopausal women can affect the quality of life in such men. Sixty patients (median age 74 years) received weekly AA for 10 weeks. Ninety-five percent of patients reported a decrease in the severity of symptoms, from a mean symptom score of 5.0 to 2.1. The authors concluded that the symptomatic improvement observed with AA was comparable with that achieved with pharmacotherapy and that, based on cost analysis, AA represented a viable alternative. (Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int. 2008 Aug 14).
FONTE: http://www.jcm.co.uk
AURICULAR ACUPUNCTURE FOR VASOMOTOR SYMPTOMS IN PROSTATE CANCER
The role of auricular acupuncture (AA) in men receiving luteinising-hormone releasing hormone (LHRH) analogues for cancer of the prostate has been investigated by a research group in the UK. Vasomotor symptoms similar to those observed in postmenopausal women can affect the quality of life in such men. Sixty patients (median age 74 years) received weekly AA for 10 weeks. Ninety-five percent of patients reported a decrease in the severity of symptoms, from a mean symptom score of 5.0 to 2.1. The authors concluded that the symptomatic improvement observed with AA was comparable with that achieved with pharmacotherapy and that, based on cost analysis, AA represented a viable alternative. (Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer. BJU Int. 2008 Aug 14).
FONTE: http://www.jcm.co.uk
Nenhum comentário:
Postar um comentário